Meeting
2019 Gastrointestinal Cancers Symposium
Retrospective analysis of clinical characteristics of mCRC patients receiving three or more lines of chemotherapy.
Authors
Pilar Garcia Alfonso
Hospital General Universitario Gregorio Marañón, Madrid, Spain
Pilar Garcia Alfonso , Íñigo Martínez Delfrade , Javier Soto Alsar , Marianela Bringas Beranek , Natalia Gutiérrez Alonso , Laura Ortega , Gabriela Torres , Andres J. Muñoz Martín , Montserrat Blanco-Codesido , Aitana Calvo , Miguel Martin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 682)
DOI
10.1200/JCO.2019.37.4_suppl.682
Abstract #
682
Poster Bd #
N7
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Small bowel adenocarcinoma: A single center experience.
First Author: Lindsay Marie Hannan
Poster
2014 ASCO Annual Meeting
Analysis of progression-free survival in the new EPOC study in an “all wild-type” population.
First Author: John A. Bridgewater
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and survival analysis in patients with isolated pulmonary metastases from colorectal cancer (CRC).
First Author: Javier Soto Alsar
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC).
First Author: Anthony B. El-Khoueiry